CAR T Cell Therapy Market
ID: MRFR/HC/6630-CR
200 Pages
Vikita Thakur
Last Updated: April 24, 2026
CAR T Cell Therapy Market Research Report: Size, Share, Trend Analysis By Therapeutic Area (Oncology, Autoimmune Diseases, Infectious Diseases), By Cell Source (Autologous, Allogeneic, Gene-Edited), \By Product - Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Breyanzi (lisocabtagene maraleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Other products), By Indication- (Leukemia, Lymphoma, Multiple Lymphoma, Other Indications), By Demographic - (Adults, Pediatrics), By End Use - (Hospitals, Cancer Treatment Centers, Specialty Clinics and Other End Users), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast Till 2035